Article Summary Illinois lawmakers passed 24 bills during the two-week fall veto session. House Bill 767 would allow IDPH Director ...

Through his leadership at the FDA's Center for Biologics Evaluation and Research (CBER), Vinay Prasad, MD, MPH has pushed out at least 7 senior leaders and created an environment that employees worry ...

Vaccine manufacturing is challenged by stringent global regulations, essential for ensuring safety and efficacy, with ...

About 1 in 4 American adults got a covid vaccine shot during the 2024-25 virus season, a fraction health care experts warn ...

"This is very exciting," says one infectious disease doctor. The new RSV vaccines were approved in 2023—and today’s research ...

The Cornwall and Isles of Scilly Commercial Research Delivery Centre (CIOS CRDC) said it was selected as a delivery site for ...

India's top drug regulator cited insufficient evidence of efficacy in the two studies conducted by Serum Institute and ICMR.

The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them.

Natasha Smith has seen her views on vaccines transform. “I had been reading books about pregnancy and parenthood of toddlers, ...

A growing number of FDA employees are eyeing the exits as chaos and uncertainty sweep through the agency, according to ...